Adrienne Victor, MD
Hematology & Oncology · Rochester, NYNPI 1144584772
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $109,574 of the $142,784 with a category attached, or 76.7%. Foundation Medicine, Inc. accounts for 97.0% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2021 at $49,049 and has fallen 95.5% since, to $2,221 in 2025. Among hematology & oncology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 52 payments — averaging $2745.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Foundation Medicine, Inc.$139K
- Springworks Therapeutics, Inc.$2K
- Sanofi$2K
- Regeneron Healthcare Solutions, Inc.$121
- E.r. Squibb & Sons, L.L.C.$19
Across 45 payments — averaging $1119.54 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Incyte Corporation$43K
- E.r. Squibb & Sons, L.L.C.$7K
- GSK$284
What the payments were for
- Consulting fees$109,57477%
- Speaking & faculty fees$31,85322%
- Travel & lodging$8191%
- Food & beverage$5190%
- Education$190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Foundation Medicine, Inc. | 46 | $138,529 |
| Springworks Therapeutics, Inc. | 1 | $2,100 |
| Sanofi | 3 | $2,015 |
| Regeneron Healthcare Solutions, Inc. | 1 | $121 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FOUNDATIONONE CDX$138,529
- FOUNDATIONFOCUS$10,914
- FOUNDATIONONE HEME$10,914
- FOUNDATIONONE$10,914
- FOUNDATIONONE LIQUID$9,910
- OGSIVEO$2,100
- FOUNDATIONACT$1,004
- LIBTAYO$334
How this compares
$142,784 in reported general payments places this provider in the 90th percentile of 967 hematology & oncology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ErivedgeVismodegib | 12 | $147,543 |
| Pazopanib Hcl | 14 | $104,447 |
| Imatinib Mesylate | 26 | $27,658 |
| Prochlorperazine Maleate | 43 | $398 |
| Dexamethasone | 18 | $111 |
| Levothyroxine Sodium | 24 | $44 |
| Pantoprazole Sodium | 12 | $28 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in Rochester
- Alex SpyropoulosRochester$633K
- Brea LipeRochester$129K
- Michael SchusterNew York$1.6M
- Charles SawyersNew York$1.6M
- Manuel Hidalgo-MedinaNew York$1.4M
- Francis ArenaLake Success$1M
- Sanjeev JainEast Patchogue$971K
- Ross LevineNew York$968K
- Perry CookBrooklyn$803K
- Mihir RavalAlbany$767K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.